However, to the best of our knowledge, aside from evidence showing that both sCD73 and sCD74 are involved in cancer immune pathway, no data are currently available on a possible correlation between them in the context of the response to anti-PD1 therapy, which represents one the results of the present study. Here, PDCD1 is linked to cancer.